FLT3 and acute myeloid leukemia: Using primary blasts of FLT3-ITD+ AML patients, it was found that midostaurin-sensitive cells harbored little phosphorylated AXL, while most midostaurin-resistant AML cells possessed a significantly higher level of AXL phosphorylation.